4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-049015
Chief Financial Officer sold 15,355 shares at $39.57 ($607,597)
- Chief Financial Officer gave up 3,293 shares (to pay taxes)
- Chief Financial Officer acquired 18,648 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…